 Kathy Goggin
Concepts (445)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 84 | 2024 | 140 | 19.890 |
Why?
| | Medication Adherence | 28 | 2023 | 59 | 5.590 |
Why?
| | Anti-HIV Agents | 23 | 2022 | 36 | 5.030 |
Why?
| | Counseling | 21 | 2022 | 60 | 4.690 |
Why?
| | Infectious Disease Transmission, Vertical | 21 | 2024 | 28 | 4.540 |
Why?
| | Female | 116 | 2024 | 3436 | 4.460 |
Why?
| | Humans | 153 | 2024 | 6599 | 4.420 |
Why?
| | Adult | 91 | 2023 | 1233 | 4.140 |
Why?
| | Male | 100 | 2023 | 3197 | 3.830 |
Why?
| | Motivational Interviewing | 16 | 2021 | 52 | 3.780 |
Why?
| | Health Knowledge, Attitudes, Practice | 19 | 2021 | 80 | 3.280 |
Why?
| | Health Promotion | 11 | 2020 | 50 | 2.660 |
Why?
| | Intention | 14 | 2021 | 24 | 2.530 |
Why?
| | Sexual Partners | 15 | 2022 | 23 | 2.460 |
Why?
| | Middle Aged | 49 | 2022 | 648 | 2.430 |
Why?
| | Smoking Cessation | 13 | 2021 | 75 | 2.410 |
Why?
| | Early Diagnosis | 16 | 2023 | 33 | 2.380 |
Why?
| | Patient Compliance | 8 | 2019 | 70 | 2.320 |
Why?
| | Pregnancy Complications, Infectious | 12 | 2022 | 26 | 2.180 |
Why?
| | Surveys and Questionnaires | 19 | 2022 | 290 | 2.080 |
Why?
| | Immunosuppressive Agents | 4 | 2019 | 37 | 2.040 |
Why?
| | Pregnancy | 31 | 2024 | 203 | 2.000 |
Why?
| | Kidney Transplantation | 4 | 2022 | 114 | 2.000 |
Why?
| | Fertilization | 11 | 2022 | 15 | 1.980 |
Why?
| | Diabetes Mellitus, Type 2 | 4 | 2023 | 44 | 1.900 |
Why?
| | Self Efficacy | 9 | 2018 | 28 | 1.890 |
Why?
| | Anti-Bacterial Agents | 3 | 2022 | 238 | 1.880 |
Why?
| | Motivation | 17 | 2021 | 64 | 1.840 |
Why?
| | Attitude of Health Personnel | 7 | 2019 | 49 | 1.820 |
Why?
| | Mass Screening | 7 | 2021 | 41 | 1.800 |
Why?
| | Young Adult | 28 | 2023 | 652 | 1.790 |
Why?
| | Adolescent | 32 | 2023 | 2087 | 1.690 |
Why?
| | Communication | 8 | 2022 | 54 | 1.680 |
Why?
| | Antiretroviral Therapy, Highly Active | 8 | 2021 | 12 | 1.630 |
Why?
| | Adolescent Health Services | 3 | 2021 | 14 | 1.630 |
Why?
| | Kenya | 25 | 2024 | 29 | 1.620 |
Why?
| | Infant | 28 | 2023 | 1396 | 1.610 |
Why?
| | Smoking | 10 | 2021 | 69 | 1.580 |
Why?
| | Uganda | 17 | 2021 | 22 | 1.580 |
Why?
| | Respiratory Tract Infections | 3 | 2022 | 75 | 1.580 |
Why?
| | Contraception | 8 | 2023 | 33 | 1.560 |
Why?
| | Patient Acceptance of Health Care | 6 | 2021 | 44 | 1.550 |
Why?
| | Religion | 4 | 2019 | 10 | 1.490 |
Why?
| | Patient Education as Topic | 6 | 2020 | 64 | 1.440 |
Why?
| | Mothers | 6 | 2022 | 37 | 1.430 |
Why?
| | Sexual Behavior | 6 | 2021 | 40 | 1.420 |
Why?
| | Health Personnel | 8 | 2021 | 28 | 1.410 |
Why?
| | Emergency Service, Hospital | 6 | 2023 | 129 | 1.400 |
Why?
| | Family Planning Services | 4 | 2018 | 5 | 1.360 |
Why?
| | Parents | 7 | 2021 | 149 | 1.240 |
Why?
| | Disease Transmission, Infectious | 5 | 2018 | 9 | 1.240 |
Why?
| | Adolescent Behavior | 4 | 2021 | 47 | 1.220 |
Why?
| | Suicide | 3 | 2023 | 7 | 1.200 |
Why?
| | Interviews as Topic | 12 | 2019 | 36 | 1.200 |
Why?
| | Parenting | 2 | 2018 | 24 | 1.160 |
Why?
| | Anti-Retroviral Agents | 12 | 2023 | 18 | 1.120 |
Why?
| | Directly Observed Therapy | 3 | 2013 | 5 | 1.110 |
Why?
| | Life Style | 5 | 2023 | 32 | 1.090 |
Why?
| | Social Support | 11 | 2020 | 38 | 1.050 |
Why?
| | Cardiovascular Diseases | 3 | 2022 | 49 | 1.030 |
Why?
| | Decision Making | 7 | 2021 | 34 | 1.010 |
Why?
| | Pre-Exposure Prophylaxis | 2 | 2022 | 3 | 0.980 |
Why?
| | Child | 20 | 2024 | 3146 | 0.970 |
Why?
| | Text Messaging | 5 | 2023 | 15 | 0.920 |
Why?
| | Aged | 15 | 2022 | 375 | 0.920 |
Why?
| | Health Behavior | 10 | 2023 | 72 | 0.920 |
Why?
| | Hospitals, Pediatric | 3 | 2022 | 178 | 0.910 |
Why?
| | Inappropriate Prescribing | 2 | 2022 | 27 | 0.870 |
Why?
| | Health Education | 7 | 2023 | 39 | 0.860 |
Why?
| | Patient Care Team | 2 | 2019 | 19 | 0.850 |
Why?
| | Behavior Therapy | 4 | 2019 | 41 | 0.840 |
Why?
| | Health Communication | 2 | 2018 | 6 | 0.820 |
Why?
| | Social Stigma | 8 | 2020 | 16 | 0.800 |
Why?
| | Psychometrics | 2 | 2018 | 33 | 0.800 |
Why?
| | Communicable Disease Control | 2 | 2018 | 7 | 0.800 |
Why?
| | Developing Countries | 5 | 2023 | 14 | 0.790 |
Why?
| | Urban Population | 5 | 2019 | 36 | 0.770 |
Why?
| | Qualitative Research | 11 | 2020 | 34 | 0.770 |
Why?
| | Practice Patterns, Physicians' | 2 | 2019 | 82 | 0.770 |
Why?
| | Point-of-Care Testing | 4 | 2021 | 7 | 0.760 |
Why?
| | Drug Monitoring | 6 | 2015 | 19 | 0.760 |
Why?
| | South Africa | 6 | 2023 | 16 | 0.750 |
Why?
| | Video Recording | 1 | 2020 | 14 | 0.750 |
Why?
| | Infant, Newborn | 16 | 2021 | 790 | 0.750 |
Why?
| | HIV | 4 | 2021 | 7 | 0.740 |
Why?
| | Preconception Care | 3 | 2018 | 4 | 0.730 |
Why?
| | Community-Institutional Relations | 2 | 2019 | 9 | 0.730 |
Why?
| | Patient-Centered Care | 2 | 2023 | 18 | 0.720 |
Why?
| | Fertility | 8 | 2018 | 15 | 0.720 |
Why?
| | Lost to Follow-Up | 1 | 2019 | 2 | 0.720 |
Why?
| | Clinical Competence | 2 | 2019 | 32 | 0.700 |
Why?
| | Reproductive Behavior | 5 | 2018 | 6 | 0.700 |
Why?
| | Ambulatory Care Facilities | 2 | 2023 | 38 | 0.690 |
Why?
| | Diet, Diabetic | 2 | 2015 | 4 | 0.680 |
Why?
| | Child, Preschool | 7 | 2022 | 1459 | 0.670 |
Why?
| | Health Services Research | 1 | 2018 | 5 | 0.670 |
Why?
| | Decision Support Systems, Clinical | 1 | 2018 | 18 | 0.660 |
Why?
| | Cost-Benefit Analysis | 7 | 2023 | 36 | 0.650 |
Why?
| | Intergenerational Relations | 1 | 2018 | 1 | 0.650 |
Why?
| | Delivery of Health Care, Integrated | 2 | 2016 | 9 | 0.650 |
Why?
| | Resilience, Psychological | 1 | 2018 | 11 | 0.640 |
Why?
| | Feasibility Studies | 8 | 2023 | 66 | 0.640 |
Why?
| | Tobacco Use Disorder | 2 | 2015 | 19 | 0.630 |
Why?
| | Kidney Failure, Chronic | 1 | 2019 | 163 | 0.620 |
Why?
| | HIV-1 | 5 | 2022 | 31 | 0.620 |
Why?
| | Pilot Projects | 11 | 2023 | 124 | 0.610 |
Why?
| | Diabetes Mellitus, Type 1 | 2 | 2015 | 108 | 0.590 |
Why?
| | Genetic Research | 1 | 2016 | 6 | 0.590 |
Why?
| | Behavior Control | 1 | 2016 | 2 | 0.580 |
Why?
| | Biomedical Research | 1 | 2016 | 20 | 0.570 |
Why?
| | Health Services Needs and Demand | 3 | 2014 | 17 | 0.560 |
Why?
| | Patient Participation | 3 | 2021 | 21 | 0.550 |
Why?
| | Epidemiological Monitoring | 1 | 2015 | 6 | 0.550 |
Why?
| | Nutrition Policy | 1 | 2015 | 5 | 0.540 |
Why?
| | Randomized Controlled Trials as Topic | 4 | 2022 | 62 | 0.530 |
Why?
| | Quality Improvement | 4 | 2021 | 60 | 0.520 |
Why?
| | Substance-Related Disorders | 5 | 2023 | 32 | 0.520 |
Why?
| | Adaptation, Psychological | 4 | 2018 | 41 | 0.510 |
Why?
| | Point-of-Care Systems | 5 | 2021 | 15 | 0.500 |
Why?
| | Time Factors | 8 | 2020 | 241 | 0.480 |
Why?
| | Physician-Patient Relations | 5 | 2021 | 24 | 0.470 |
Why?
| | Hospitals | 4 | 2023 | 38 | 0.460 |
Why?
| | Community-Based Participatory Research | 3 | 2017 | 10 | 0.460 |
Why?
| | HIV Seropositivity | 6 | 2012 | 8 | 0.450 |
Why?
| | Treatment Outcome | 11 | 2022 | 624 | 0.450 |
Why?
| | United States | 13 | 2021 | 646 | 0.440 |
Why?
| | Community Health Workers | 2 | 2023 | 6 | 0.420 |
Why?
| | Papillomavirus Infections | 2 | 2022 | 7 | 0.420 |
Why?
| | Papillomavirus Vaccines | 2 | 2022 | 8 | 0.420 |
Why?
| | Homosexuality, Male | 6 | 2014 | 7 | 0.420 |
Why?
| | Cross-Sectional Studies | 9 | 2019 | 317 | 0.420 |
Why?
| | Suicidal Ideation | 2 | 2022 | 7 | 0.410 |
Why?
| | Reproduction | 3 | 2021 | 7 | 0.400 |
Why?
| | Contraceptive Agents | 3 | 2023 | 15 | 0.400 |
Why?
| | Community Health Services | 2 | 2009 | 9 | 0.400 |
Why?
| | Truth Disclosure | 2 | 2019 | 5 | 0.390 |
Why?
| | Longitudinal Studies | 10 | 2018 | 123 | 0.390 |
Why?
| | Opioid-Related Disorders | 2 | 2021 | 15 | 0.390 |
Why?
| | Acquired Immunodeficiency Syndrome | 6 | 2012 | 8 | 0.380 |
Why?
| | Education, Pharmacy | 1 | 2010 | 2 | 0.380 |
Why?
| | Students, Pharmacy | 1 | 2010 | 2 | 0.380 |
Why?
| | Educational Measurement | 1 | 2010 | 7 | 0.380 |
Why?
| | Attitude to Health | 3 | 2019 | 35 | 0.370 |
Why?
| | Telemedicine | 3 | 2022 | 64 | 0.360 |
Why?
| | Follow-Up Studies | 4 | 2019 | 315 | 0.360 |
Why?
| | Risk Reduction Behavior | 3 | 2020 | 14 | 0.360 |
Why?
| | Safe Sex | 3 | 2018 | 5 | 0.350 |
Why?
| | Viral Load | 6 | 2022 | 20 | 0.350 |
Why?
| | Depression | 5 | 2021 | 68 | 0.350 |
Why?
| | Health Services Accessibility | 3 | 2020 | 34 | 0.340 |
Why?
| | Research Design | 3 | 2019 | 64 | 0.340 |
Why?
| | Infant, Newborn, Diseases | 2 | 2021 | 32 | 0.340 |
Why?
| | Patient Selection | 3 | 2019 | 40 | 0.330 |
Why?
| | Program Evaluation | 5 | 2023 | 52 | 0.310 |
Why?
| | Multiple Sclerosis, Relapsing-Remitting | 2 | 2018 | 8 | 0.310 |
Why?
| | Missouri | 6 | 2022 | 78 | 0.310 |
Why?
| | Decision Support Techniques | 2 | 2019 | 9 | 0.310 |
Why?
| | Multiple Sclerosis | 2 | 2017 | 18 | 0.300 |
Why?
| | Religion and Medicine | 2 | 2017 | 4 | 0.300 |
Why?
| | Data Collection | 4 | 2014 | 32 | 0.290 |
Why?
| | Polymerase Chain Reaction | 3 | 2021 | 82 | 0.290 |
Why?
| | Heart Defects, Congenital | 2 | 2018 | 81 | 0.280 |
Why?
| | Midwestern United States | 2 | 2016 | 39 | 0.280 |
Why?
| | Reproducibility of Results | 4 | 2019 | 197 | 0.260 |
Why?
| | Unsafe Sex | 2 | 2015 | 4 | 0.260 |
Why?
| | Reproductive Health | 2 | 2016 | 11 | 0.260 |
Why?
| | Logistic Models | 4 | 2018 | 91 | 0.250 |
Why?
| | Depressive Disorder | 4 | 1998 | 11 | 0.250 |
Why?
| | Pregnant Women | 2 | 2024 | 7 | 0.240 |
Why?
| | Maternal Health Services | 1 | 2024 | 3 | 0.240 |
Why?
| | Socioeconomic Factors | 6 | 2013 | 63 | 0.240 |
Why?
| | Peer Group | 2 | 2020 | 9 | 0.240 |
Why?
| | Patient Satisfaction | 3 | 2018 | 41 | 0.240 |
Why?
| | Mobile Applications | 2 | 2014 | 17 | 0.230 |
Why?
| | Pregnancy in Adolescence | 1 | 2023 | 5 | 0.230 |
Why?
| | Protestantism | 2 | 2020 | 6 | 0.230 |
Why?
| | Intrauterine Devices | 1 | 2023 | 4 | 0.230 |
Why?
| | Postnatal Care | 2 | 2020 | 4 | 0.230 |
Why?
| | Cooperative Behavior | 3 | 2018 | 26 | 0.230 |
Why?
| | Prescriptions | 1 | 2022 | 10 | 0.230 |
Why?
| | Diabetes Mellitus | 2 | 2020 | 21 | 0.220 |
Why?
| | Serologic Tests | 2 | 2019 | 6 | 0.220 |
Why?
| | Triglycerides | 1 | 2022 | 20 | 0.210 |
Why?
| | Kansas | 5 | 2016 | 49 | 0.210 |
Why?
| | Weight Loss | 1 | 2022 | 39 | 0.210 |
Why?
| | Professional-Patient Relations | 2 | 2018 | 8 | 0.210 |
Why?
| | Women | 1 | 2001 | 1 | 0.200 |
Why?
| | Medicine | 1 | 2021 | 10 | 0.200 |
Why?
| | Life Change Events | 1 | 2001 | 4 | 0.200 |
Why?
| | Risk Assessment | 1 | 2022 | 130 | 0.200 |
Why?
| | Models, Statistical | 3 | 2016 | 34 | 0.200 |
Why?
| | Pandemics | 1 | 2022 | 78 | 0.200 |
Why?
| | Feedback | 2 | 2021 | 7 | 0.200 |
Why?
| | Outpatients | 1 | 2020 | 28 | 0.190 |
Why?
| | Health Plan Implementation | 1 | 2020 | 10 | 0.190 |
Why?
| | Prevalence | 3 | 2017 | 145 | 0.190 |
Why?
| | Program Development | 2 | 2017 | 16 | 0.190 |
Why?
| | Infant Mortality | 1 | 2020 | 4 | 0.190 |
Why?
| | Health Status Disparities | 2 | 2017 | 22 | 0.180 |
Why?
| | Personal Satisfaction | 1 | 2019 | 9 | 0.180 |
Why?
| | Ambulatory Care | 1 | 2020 | 46 | 0.180 |
Why?
| | Retrospective Studies | 6 | 2021 | 1251 | 0.180 |
Why?
| | Hospitals, Urban | 1 | 2019 | 6 | 0.180 |
Why?
| | Combined Modality Therapy | 3 | 2015 | 51 | 0.180 |
Why?
| | Bisexuality | 3 | 2014 | 3 | 0.180 |
Why?
| | Reminder Systems | 2 | 2021 | 5 | 0.180 |
Why?
| | Drug-Eluting Stents | 1 | 2019 | 2 | 0.170 |
Why?
| | Percutaneous Coronary Intervention | 1 | 2019 | 2 | 0.170 |
Why?
| | Referral and Consultation | 2 | 2016 | 33 | 0.170 |
Why?
| | Religious Personnel | 1 | 2019 | 3 | 0.170 |
Why?
| | Reproductive Health Services | 1 | 2019 | 3 | 0.170 |
Why?
| | RNA, Viral | 3 | 2015 | 16 | 0.170 |
Why?
| | Clinical Decision-Making | 1 | 2019 | 20 | 0.170 |
Why?
| | Abortion, Spontaneous | 1 | 2018 | 1 | 0.170 |
Why?
| | Pregnancy Rate | 1 | 2018 | 1 | 0.170 |
Why?
| | Live Birth | 1 | 2018 | 1 | 0.170 |
Why?
| | Evidence-Based Medicine | 1 | 2019 | 43 | 0.170 |
Why?
| | Hospitalists | 1 | 2019 | 9 | 0.170 |
Why?
| | Stillbirth | 1 | 2018 | 2 | 0.170 |
Why?
| | Translations | 1 | 2018 | 5 | 0.170 |
Why?
| | Prognosis | 1 | 2019 | 209 | 0.170 |
Why?
| | Perception | 1 | 2018 | 9 | 0.170 |
Why?
| | Self Report | 2 | 2018 | 43 | 0.170 |
Why?
| | Nurses | 1 | 2018 | 10 | 0.170 |
Why?
| | Prenatal Care | 1 | 2018 | 4 | 0.160 |
Why?
| | Physicians | 1 | 2018 | 22 | 0.160 |
Why?
| | Protective Factors | 1 | 2018 | 8 | 0.160 |
Why?
| | Sexuality | 2 | 2015 | 4 | 0.160 |
Why?
| | Sexual Dysfunctions, Psychological | 1 | 1998 | 1 | 0.160 |
Why?
| | Dehydroepiandrosterone Sulfate | 1 | 1998 | 2 | 0.160 |
Why?
| | Testosterone | 1 | 1998 | 11 | 0.160 |
Why?
| | Culturally Competent Care | 1 | 2017 | 1 | 0.160 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2018 | 39 | 0.160 |
Why?
| | Mood Disorders | 1 | 1998 | 8 | 0.160 |
Why?
| | Clinical Protocols | 1 | 2018 | 35 | 0.160 |
Why?
| | Primary Health Care | 1 | 2018 | 44 | 0.160 |
Why?
| | Poverty | 1 | 2018 | 28 | 0.160 |
Why?
| | Drug Administration Schedule | 4 | 2016 | 40 | 0.160 |
Why?
| | Executive Function | 1 | 2017 | 11 | 0.150 |
Why?
| | Cohort Studies | 5 | 2018 | 264 | 0.150 |
Why?
| | Clinical Trials as Topic | 2 | 2014 | 44 | 0.150 |
Why?
| | Risk-Taking | 1 | 2016 | 11 | 0.150 |
Why?
| | Hospitals, Public | 1 | 2016 | 2 | 0.150 |
Why?
| | Research Subjects | 1 | 2016 | 3 | 0.150 |
Why?
| | Computers, Handheld | 2 | 2016 | 11 | 0.150 |
Why?
| | Choice Behavior | 1 | 2016 | 6 | 0.150 |
Why?
| | Continuity of Patient Care | 1 | 2016 | 7 | 0.150 |
Why?
| | Prospective Studies | 5 | 2017 | 508 | 0.150 |
Why?
| | Insemination, Artificial | 1 | 2016 | 1 | 0.140 |
Why?
| | AIDS Serodiagnosis | 1 | 2016 | 1 | 0.140 |
Why?
| | Cardiology Service, Hospital | 1 | 2016 | 4 | 0.140 |
Why?
| | Tobacco Use Cessation | 1 | 2016 | 2 | 0.140 |
Why?
| | Pediatrics | 1 | 2018 | 170 | 0.140 |
Why?
| | Guideline Adherence | 1 | 2016 | 33 | 0.140 |
Why?
| | Predictive Value of Tests | 3 | 2016 | 99 | 0.140 |
Why?
| | Focus Groups | 2 | 2020 | 13 | 0.140 |
Why?
| | Cardiac Surgical Procedures | 1 | 2016 | 30 | 0.140 |
Why?
| | Abnormalities, Drug-Induced | 1 | 2015 | 9 | 0.140 |
Why?
| | Treatment Refusal | 1 | 2015 | 6 | 0.140 |
Why?
| | Antirheumatic Agents | 1 | 2015 | 14 | 0.140 |
Why?
| | Inpatients | 1 | 2016 | 44 | 0.140 |
Why?
| | Peer Influence | 1 | 2015 | 2 | 0.140 |
Why?
| | Diet | 2 | 2014 | 54 | 0.140 |
Why?
| | Diet Records | 1 | 2015 | 6 | 0.140 |
Why?
| | Isoniazid | 1 | 2015 | 1 | 0.140 |
Why?
| | Fabaceae | 1 | 2015 | 1 | 0.140 |
Why?
| | Heart Ventricles | 1 | 2016 | 50 | 0.140 |
Why?
| | Plant Leaves | 1 | 2015 | 2 | 0.140 |
Why?
| | Tuberculosis, Pulmonary | 1 | 2015 | 2 | 0.140 |
Why?
| | Opportunistic Infections | 1 | 2015 | 7 | 0.140 |
Why?
| | Public Health | 1 | 2015 | 20 | 0.130 |
Why?
| | Food Preferences | 1 | 2015 | 12 | 0.130 |
Why?
| | Hypoglycemic Agents | 1 | 2015 | 32 | 0.130 |
Why?
| | Artificial Intelligence | 1 | 2015 | 9 | 0.130 |
Why?
| | Insulin | 1 | 2015 | 46 | 0.130 |
Why?
| | Food | 1 | 2015 | 18 | 0.130 |
Why?
| | Heterosexuality | 1 | 2014 | 1 | 0.130 |
Why?
| | Health Policy | 1 | 2014 | 13 | 0.130 |
Why?
| | Quality of Health Care | 1 | 2014 | 13 | 0.120 |
Why?
| | Adenine | 1 | 2014 | 1 | 0.120 |
Why?
| | Hair | 1 | 2014 | 1 | 0.120 |
Why?
| | Organophosphonates | 1 | 2014 | 1 | 0.120 |
Why?
| | Personnel, Hospital | 1 | 2014 | 6 | 0.120 |
Why?
| | Practice Guidelines as Topic | 1 | 2014 | 96 | 0.120 |
Why?
| | Alcohol-Related Disorders | 1 | 2013 | 1 | 0.110 |
Why?
| | Obesity | 1 | 2014 | 124 | 0.110 |
Why?
| | Pregnancy, Unplanned | 2 | 2023 | 9 | 0.110 |
Why?
| | Audiovisual Aids | 1 | 2012 | 4 | 0.110 |
Why?
| | Electronics, Medical | 1 | 2012 | 5 | 0.110 |
Why?
| | Health Resources | 1 | 2012 | 17 | 0.110 |
Why?
| | Internal-External Control | 2 | 2009 | 4 | 0.110 |
Why?
| | Vaccination | 2 | 2022 | 68 | 0.100 |
Why?
| | Teaching | 1 | 2010 | 4 | 0.100 |
Why?
| | Faculty | 1 | 2010 | 4 | 0.090 |
Why?
| | Psychology | 1 | 2010 | 6 | 0.090 |
Why?
| | Laboratories | 2 | 2021 | 16 | 0.090 |
Why?
| | Interpersonal Relations | 2 | 2017 | 13 | 0.090 |
Why?
| | Cultural Characteristics | 1 | 2009 | 3 | 0.090 |
Why?
| | Anxiety Disorders | 2 | 2000 | 21 | 0.090 |
Why?
| | Quality of Life | 3 | 1998 | 131 | 0.080 |
Why?
| | Aged, 80 and over | 2 | 2020 | 150 | 0.080 |
Why?
| | Needs Assessment | 2 | 2018 | 21 | 0.080 |
Why?
| | Self Concept | 2 | 2001 | 12 | 0.080 |
Why?
| | Inservice Training | 1 | 2007 | 3 | 0.080 |
Why?
| | Telephone | 2 | 2017 | 12 | 0.070 |
Why?
| | Spirituality | 1 | 2006 | 1 | 0.070 |
Why?
| | Alcoholism | 1 | 2006 | 5 | 0.070 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2016 | 92 | 0.070 |
Why?
| | Risk Factors | 2 | 2018 | 460 | 0.060 |
Why?
| | Regression Analysis | 2 | 2017 | 56 | 0.060 |
Why?
| | Administration, Oral | 2 | 2015 | 59 | 0.060 |
Why?
| | Age Factors | 2 | 2022 | 203 | 0.060 |
Why?
| | Africa, Eastern | 1 | 2023 | 1 | 0.060 |
Why?
| | Tertiary Healthcare | 1 | 2023 | 5 | 0.060 |
Why?
| | Trust | 1 | 2022 | 5 | 0.060 |
Why?
| | Papillomaviridae | 1 | 2022 | 2 | 0.060 |
Why?
| | Systems Analysis | 1 | 2022 | 2 | 0.060 |
Why?
| | Multicenter Studies as Topic | 1 | 2022 | 17 | 0.050 |
Why?
| | Health Expenditures | 1 | 2022 | 15 | 0.050 |
Why?
| | Drug Resistance, Viral | 1 | 2022 | 3 | 0.050 |
Why?
| | Multivariate Analysis | 2 | 2013 | 74 | 0.050 |
Why?
| | Insurance, Health | 1 | 2022 | 17 | 0.050 |
Why?
| | Sex Factors | 1 | 2022 | 71 | 0.050 |
Why?
| | Harm Reduction | 1 | 2021 | 4 | 0.050 |
Why?
| | Postpartum Period | 1 | 2021 | 8 | 0.050 |
Why?
| | New York City | 1 | 2001 | 2 | 0.050 |
Why?
| | Emotions | 1 | 2001 | 23 | 0.050 |
Why?
| | Neuropsychological Tests | 2 | 1998 | 15 | 0.050 |
Why?
| | Genetic Testing | 1 | 2021 | 74 | 0.050 |
Why?
| | Self Disclosure | 1 | 2000 | 6 | 0.050 |
Why?
| | Drug Therapy, Combination | 2 | 2016 | 38 | 0.050 |
Why?
| | Contraception Behavior | 1 | 2020 | 11 | 0.050 |
Why?
| | Public Health Surveillance | 1 | 2020 | 5 | 0.050 |
Why?
| | Anxiety | 1 | 2000 | 45 | 0.050 |
Why?
| | Odds Ratio | 1 | 2020 | 53 | 0.050 |
Why?
| | Infant Care | 1 | 2019 | 4 | 0.050 |
Why?
| | Parturition | 1 | 2019 | 2 | 0.050 |
Why?
| | Attitude | 1 | 2019 | 12 | 0.050 |
Why?
| | Cultural Competency | 1 | 2019 | 1 | 0.050 |
Why?
| | CD4 Lymphocyte Count | 2 | 2015 | 4 | 0.040 |
Why?
| | Personal Autonomy | 1 | 2019 | 4 | 0.040 |
Why?
| | Language | 1 | 2019 | 6 | 0.040 |
Why?
| | Prosthesis Design | 1 | 2019 | 9 | 0.040 |
Why?
| | Patient Preference | 1 | 2019 | 6 | 0.040 |
Why?
| | Pregnancy Complications | 1 | 2019 | 8 | 0.040 |
Why?
| | Risk | 1 | 2019 | 40 | 0.040 |
Why?
| | Comorbidity | 4 | 2000 | 61 | 0.040 |
Why?
| | Sick Role | 1 | 1998 | 3 | 0.040 |
Why?
| | Disability Evaluation | 1 | 1998 | 10 | 0.040 |
Why?
| | Health Care Surveys | 1 | 2019 | 32 | 0.040 |
Why?
| | Activities of Daily Living | 1 | 1998 | 12 | 0.040 |
Why?
| | Mental Processes | 1 | 1998 | 1 | 0.040 |
Why?
| | Psychomotor Performance | 1 | 1998 | 6 | 0.040 |
Why?
| | Psychotherapy, Group | 1 | 1998 | 3 | 0.040 |
Why?
| | Home Care Services | 1 | 2018 | 7 | 0.040 |
Why?
| | Statistics, Nonparametric | 1 | 2018 | 19 | 0.040 |
Why?
| | Fluoxetine | 1 | 1998 | 6 | 0.040 |
Why?
| | Medical Records | 1 | 2018 | 14 | 0.040 |
Why?
| | Cross-Over Studies | 1 | 2018 | 32 | 0.040 |
Why?
| | Pregnancy Outcome | 1 | 2018 | 4 | 0.040 |
Why?
| | Pain | 1 | 1998 | 53 | 0.040 |
Why?
| | Monitoring, Physiologic | 1 | 2018 | 24 | 0.040 |
Why?
| | Libido | 1 | 1998 | 1 | 0.040 |
Why?
| | Dysthymic Disorder | 1 | 1998 | 1 | 0.040 |
Why?
| | Health Priorities | 1 | 2017 | 3 | 0.040 |
Why?
| | Reference Values | 1 | 1998 | 40 | 0.040 |
Why?
| | Health Status | 1 | 2017 | 28 | 0.040 |
Why?
| | Gene Products, tat | 1 | 2017 | 1 | 0.040 |
Why?
| | Task Performance and Analysis | 1 | 1997 | 4 | 0.040 |
Why?
| | Social Norms | 1 | 2017 | 1 | 0.040 |
Why?
| | Stroke | 1 | 2017 | 24 | 0.040 |
Why?
| | Gender Identity | 1 | 2017 | 4 | 0.040 |
Why?
| | Disease Progression | 1 | 2017 | 104 | 0.040 |
Why?
| | Specimen Handling | 1 | 2017 | 18 | 0.040 |
Why?
| | Psychiatric Status Rating Scales | 2 | 2012 | 16 | 0.040 |
Why?
| | Delivery of Health Care | 1 | 2017 | 29 | 0.040 |
Why?
| | Government | 1 | 2016 | 1 | 0.040 |
Why?
| | Lamivudine | 1 | 2016 | 1 | 0.040 |
Why?
| | Zidovudine | 1 | 2016 | 3 | 0.040 |
Why?
| | Universities | 1 | 2016 | 14 | 0.040 |
Why?
| | Gestational Age | 1 | 2016 | 61 | 0.040 |
Why?
| | Remote Sensing Technology | 1 | 2016 | 4 | 0.040 |
Why?
| | Cloud Computing | 1 | 2016 | 5 | 0.040 |
Why?
| | Diffusion of Innovation | 1 | 2016 | 7 | 0.040 |
Why?
| | Hospitals, University | 1 | 2016 | 4 | 0.040 |
Why?
| | Models, Organizational | 1 | 2016 | 8 | 0.040 |
Why?
| | Attitude to Computers | 1 | 2016 | 5 | 0.040 |
Why?
| | Factor Analysis, Statistical | 1 | 2016 | 24 | 0.040 |
Why?
| | Students | 1 | 2016 | 43 | 0.040 |
Why?
| | Teratogens | 1 | 2015 | 5 | 0.040 |
Why?
| | Contraception, Postcoital | 1 | 2016 | 8 | 0.030 |
Why?
| | Condoms | 1 | 2016 | 5 | 0.030 |
Why?
| | Caregivers | 1 | 2016 | 38 | 0.030 |
Why?
| | Drug Prescriptions | 1 | 2015 | 22 | 0.030 |
Why?
| | Herb-Drug Interactions | 1 | 2015 | 1 | 0.030 |
Why?
| | Child Nutrition Sciences | 1 | 2015 | 3 | 0.030 |
Why?
| | Antitubercular Agents | 1 | 2015 | 7 | 0.030 |
Why?
| | Patient Safety | 1 | 2015 | 20 | 0.030 |
Why?
| | Food Supply | 1 | 2015 | 10 | 0.030 |
Why?
| | Family Characteristics | 1 | 2015 | 10 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2015 | 31 | 0.030 |
Why?
| | Treatment Failure | 1 | 2015 | 17 | 0.030 |
Why?
| | Electronic Health Records | 1 | 2015 | 61 | 0.030 |
Why?
| | Directive Counseling | 1 | 2014 | 6 | 0.030 |
Why?
| | Goals | 1 | 2014 | 8 | 0.030 |
Why?
| | Minority Groups | 1 | 2014 | 18 | 0.030 |
Why?
| | Reproductive Medicine | 1 | 2014 | 2 | 0.030 |
Why?
| | Confidentiality | 1 | 2014 | 6 | 0.030 |
Why?
| | Tenofovir | 1 | 2014 | 1 | 0.030 |
Why?
| | Demography | 1 | 2014 | 10 | 0.030 |
Why?
| | Body Mass Index | 1 | 2014 | 155 | 0.030 |
Why?
| | Information Systems | 1 | 2013 | 1 | 0.030 |
Why?
| | Binge Drinking | 1 | 2012 | 2 | 0.030 |
Why?
| | Child Behavior | 1 | 1993 | 30 | 0.030 |
Why?
| | Sex Counseling | 1 | 2012 | 1 | 0.030 |
Why?
| | Vegetables | 1 | 2012 | 9 | 0.030 |
Why?
| | Fruit | 1 | 2012 | 11 | 0.030 |
Why?
| | Varenicline | 1 | 2012 | 4 | 0.030 |
Why?
| | Quinoxalines | 1 | 2012 | 4 | 0.030 |
Why?
| | Benzazepines | 1 | 2012 | 6 | 0.030 |
Why?
| | Nicotinic Antagonists | 1 | 2012 | 9 | 0.030 |
Why?
| | North America | 1 | 2012 | 42 | 0.030 |
Why?
| | Brazil | 1 | 2012 | 1 | 0.030 |
Why?
| | Cross-Cultural Comparison | 1 | 2012 | 3 | 0.030 |
Why?
| | Baltimore | 1 | 2012 | 8 | 0.030 |
Why?
| | Cognition Disorders | 1 | 2011 | 13 | 0.030 |
Why?
| | Exercise | 1 | 1993 | 125 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2011 | 142 | 0.020 |
Why?
| | Personality Inventory | 1 | 2009 | 2 | 0.020 |
Why?
| | Consumer Health Information | 1 | 2009 | 2 | 0.020 |
Why?
| | Models, Psychological | 1 | 2009 | 8 | 0.020 |
Why?
| | Self Care | 1 | 2009 | 24 | 0.020 |
Why?
| | Healthcare Disparities | 1 | 2009 | 20 | 0.020 |
Why?
| | Alcoholics Anonymous | 1 | 2006 | 1 | 0.020 |
Why?
| | Alcohol Drinking | 1 | 2006 | 7 | 0.020 |
Why?
| | Analysis of Variance | 1 | 1998 | 24 | 0.010 |
Why?
| | Depressive Disorder, Major | 1 | 1998 | 14 | 0.010 |
Why?
| | Patient Dropouts | 1 | 1998 | 3 | 0.010 |
Why?
| | Placebos | 1 | 1998 | 6 | 0.010 |
Why?
| | Educational Status | 1 | 1998 | 20 | 0.010 |
Why?
| | Double-Blind Method | 1 | 1998 | 48 | 0.010 |
Why?
| | Nausea | 1 | 1998 | 15 | 0.010 |
Why?
| | Headache | 1 | 1998 | 15 | 0.010 |
Why?
| | Fatigue | 1 | 1998 | 13 | 0.010 |
Why?
| | Child Development | 1 | 1993 | 42 | 0.010 |
Why?
|
|
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Physical Neighbors People whose addresses are nearby this person. _
|